As filed with the Securities and Exchange Commission on September 29, 2005
REGISTRATION NO. 333 -
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
under the
SECURITIES ACT OF 1933
COLEY PHARMACEUTICAL GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 06-1506689 | |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
93 Worcester Street, Suite 100
Wellesley, Massachusetts 02481
(Address, Including Zip Code, of Principal Executive Offices)
Coley Pharmaceutical Group, Inc. 1997 Employee, Director and Consultant Stock Option Plan
Coley Pharmaceutical Group, Inc. 2005 Stock Plan
(Full Titles of the Plans)
Robert L. Bratzler, Ph.D.
Coley Pharmaceutical Group, Inc.
93 Worcester Street, Suite 101
Wellesley, Massachusetts 02481
(Name, Address and Telephone Number, Including Area Code, of Agent For Service)
with a copy to:
William T. Whelan, Esq.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, Massachusetts 0211
(617) 542-2241
CALCULATION OF REGISTRATION FEE
| Title of Securities to be Registered | Amount to be Registered(1) | Proposed Maximum Offering Price Per Share (2) | Proposed Maximum Aggregate Offering Price(2) | Amount of Registration Fee | |||||||
Common Stock, $0.01 par value | 21,834 shares | $ | 0.23 | $ | 5,021.82 | $ | 0.59 | ||||
| 2,554,375 shares | $ | 1.15 | $ | 2,937,531.25 | $ | 345.75 | |||||
| 33,624 shares | $ | 1.88 | $ | 63,213.12 | $ | 7.44 | |||||
| 2,620 shares | $ | 3.66 | $ | 9,589.20 | $ | 1.13 | |||||
| 29,227 shares | $ | 4.58 | $ | 133,859.66 | $ | 15.76 | |||||
| 12,119 shares | $ | 4.85 | $ | 58,777.15 | $ | 6.92 | |||||
| 39,739 shares | $ | 9.16 | $ | 364,009.24 | $ | 42.84 | |||||
| 19,214 shares | $ | 13.74 | $ | 264,000.36 | $ | 31.07 | |||||
| 2,620 shares | $ | 16.99 | $ | 44,513.80 | $ | 5.24 | |||||
| 147,467 shares | $ | 18.32 | $ | 2,701,595.44 | $ | 317.98 | |||||
| 618,035 shares | $ | 16.00 | $ | 9,888,560.00 | $ | 1,163.88 | |||||
| 1,783,712 shares | $ | 15.64 | $ | 27,897,255.68 | $ | 3,283.51 | |||||
| $ | 5,222.11 | ||||||||||
| (1) | The number of shares of common stock, par value $0.01 per share (“Common Stock”), stated above consists of the aggregate number of shares which may be sold upon the exercise of options or issuance of stock awards which (i) have been granted under the Coley Pharmaceutical Group, Inc. 1997 Employee, Director and Consultant Stock Option Plan (the “1997 Plan”) and (ii) have been granted or may hereafter be granted under the Coley Pharmaceutical Group, Inc. 2005 Stock Plan (the “2005 Plan”). The maximum number of shares which may be sold upon the exercise of such options or issuance of stock awards granted under the 1997 Plan and the 2005 Plan is subject to adjustment in accordance with certain anti-dilution and other provisions of the 1997 Plan and 2005 Plan. Accordingly, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement covers, in addition to the number of shares stated above, an indeterminate number of shares which may be subject to grant or otherwise issuable after the operation of any such anti-dilution and other provisions. |
| (2) | This calculation is made solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and (h) under the Securities Act as follows: (i) in the case of shares of Common Stock which may be purchased upon exercise of outstanding options, the fee is calculated on the basis of the price at which the options may be exercised; and (ii) in the case of shares of Common Stock for which options and stock awards have not yet been granted and the option price of which is therefore unknown, the fee is calculated on the basis of the average of the high and low sale prices per share of the Common Stock on the Nasdaq National Market as of a date (September 23, 2005) within five business days prior to filing this Registration Statement. |
EXPLANATORY NOTE
In accordance with the instructional Note to Part I of Form S-8 as promulgated by the Securities and Exchange Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement on Form S-8 for offers of Common Stock pursuant to the 1997 Plan and the 2005 Plan.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Registrant with the Securities and Exchange Commission (the “Commission”) are incorporated herein by reference:
| (1) | The Registrant’s Prospectus filed pursuant to Rule 424(b), filed with the Commission on August 10, 2005 (File No. 333-124176). |
| (2) | The Registrant’s Quarterly Report on Form 10-Q, filed with the Commission on September 16, 2005 (File No. 000-51472). |
| (3) | The Registrant’s Current Report on Form 8-K, filed with the Commission on August 18, 2005 (File No. 000-51472). |
| (4) | The Registrant’s Current Report on Form 8-K, filed with the Commission on September 27, 2005 (File No. 000-51472). |
| (5) | The description of the Registrant’s Common Stock contained in the Registrant’s Registration Statement on Form 8-A, filed with the Commission on August 3, 2005 (File No. 000-51472), including any amendment or report filed for the purpose of updating such description. |
All reports and other documents filed by the Registrant after the date hereof pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such reports and documents.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and members of that firm, their families and trusts for their benefit own an aggregate of 98,686 shares of Common Stock of the Registrant and options and warrants to purchase 9,804 shares of Common Stock of the Registrant.
Item 6. Indemnification of Directors and Officers.
Incorporated by reference from Part II, Item 14 of the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176).
II-1
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
| (4.1) | Restated Certificate of Incorporation of the Registrant. Filed as Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. |
| (4.2) | Restated Bylaws of the Registrant. Filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. |
| (4.3) | Form of Common Stock Certificate. Filed as Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. |
| (5) | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of shares being registered. Filed herewith. |
| (23.1) | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in opinion of counsel filed as Exhibit 5). |
| (23.2) | Consent of PricewaterhouseCoopers, LLP. Filed herewith. |
| (24) | Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement). |
| (99.1) | Coley Pharmaceutical Group, Inc. 1997 Employee, Director and Consultant Stock Option Plan. Filed as Exhibit 10.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. |
| (99.2) | Coley Pharmaceutical Group, Inc. 2005 Stock Plan. Filed as Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. |
Item 9. Undertakings.
| (a) | The undersigned Registrant hereby undertakes: |
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement.
II-2
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the Registration Statement is on Form S-3, Form S-8 or Form F-3, and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this Registration Statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
| (b) | The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| (c) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Wellesley, Massachusetts on September 29, 2005.
| COLEY PHARMACEUTICAL GROUP, INC. | ||
By: | /s/ Robert L. Bratzler | |
| Robert L. Bratzler, Ph.D. | ||
President and Chief Executive Officer | ||
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Robert L. Bratzler, Charles Abdalian and Charles Yon, and each of them singly, his/her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him/her and in his/her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of Coley Pharmaceutical Group, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any of each of them or their substitute may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Robert L. Bratzler | President, Chief Executive Officer and Director (principal executive officer) | September 29, 2005 | ||
Robert L. Bratzler, Ph.D. | ||||
/s/ Charles Abdalian | Chief Financial Officer (principal financial and accounting officer) | September 29, 2005 | ||
Charles Abdalian | ||||
/s/ Kenneth M. Bate | Director | September 29, 2005 | ||
Kenneth M. Bate | ||||
/s/ Gert Caspritz | Director | September 29, 2005 | ||
Gert Caspritz, Ph.D. | ||||
II-4
/s/ Anthony B. Evnin | Director | September 29, 2005 | ||
Anthony B. Evnin, Ph.D. | ||||
/s/ Manfred Karobath | Director | September 29, 2005 | ||
Manfred Karobath, M.D. | ||||
/s/ James E. Thomas | Director | September 29, 2005 | ||
James E. Thomas | ||||
/s/ Robert J. Hugin | Director | September 29, 2005 | ||
Robert J. Hugin | ||||
/s/ Patrick Langlois | Director | September 29, 2005 | ||
Patrick Langlois, Ph.D. | ||||
II-5
COLEY PHARMACEUTICAL GROUP, INC.
INDEX TO EXHIBITS FILED WITH
FORM S-8 REGISTRATION STATEMENT
| Exhibit Number | Description | |
| (4.1) | Restated Certificate of Incorporation of the Registrant. Filed as Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. | |
| (4.2) | Restated Bylaws of the Registrant. Filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. | |
| (4.3) | Form of Common Stock Certificate. Filed as Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. | |
| (5) | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of shares being registered. Filed herewith. | |
| (23.1) | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in opinion of counsel filed as Exhibit 5). | |
| (23.2) | Consent of PricewaterhouseCoopers, LLP. Filed herewith. | |
| (24) | Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement). | |
| (99.1) | Coley Pharmaceutical Group, Inc. 1997 Employee, Director and Consultant Stock Option Plan. Filed as Exhibit 10.1 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. | |
| (99.2) | Coley Pharmaceutical Group, Inc. 2005 Stock Plan. Filed as Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-124176) and incorporated herein by reference. | |
II-6
